DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Deitcher SR. et al.
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.
Clin Appl Thromb Hemost 2006;
12: 389-396.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.